Global Swine Live Vaccine Market Research Report 2025(Status and Outlook)
Description
Report Overview
The swine live vaccine market encompasses biological preparations designed to stimulate immunity in pigs against specific diseases, utilizing attenuated or modified live pathogens that replicate within the host to induce a robust immune response. These vaccines are critical in preventing outbreaks of diseases such as porcine reproductive and respiratory syndrome (PRRS), classical swine fever (CSF), and porcine circovirus-associated diseases (PCVAD), which can cause significant economic losses in the swine industry. The market is driven by increasing pork consumption, rising awareness of animal health, and stringent biosecurity regulations in livestock farming. Technological advancements in vaccine development, such as vector-based and recombinant DNA vaccines, are enhancing efficacy and safety. However, challenges include high R&D costs, regulatory hurdles, and the need for cold chain logistics to maintain vaccine viability. Geographically, Asia-Pacific dominates due to large-scale pig farming in China and Vietnam, while North America and Europe focus on advanced vaccine solutions to meet stringent food safety standards. The growing trend toward antibiotic-free farming further boosts demand for effective live vaccines as alternatives to antimicrobials. Key players in the market include Zoetis, Merck Animal Health, Boehringer Ingelheim, and Ceva Santé Animale, who invest heavily in innovation and strategic partnerships to expand their product portfolios and global reach.
The global Swine Live Vaccine market size was estimated at USD 1952.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.12% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Swine Live Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Swine Live Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Swine Live Vaccine market.
Global Swine Live Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boehringer Ingelheim
Harbin Pharmaceutical Group Bio-vaccine
DHN
Shenzhen BIOCBD Biotechnology
Jinyu Biotechnology
Zhongmu Industry
Qindao Lijian Bio-Tech
Wuhan Keqian Biology
Ceva Corporate
KM Biologics
Nisseiken
Market Segmentation (by Type)
Porcine Reproductive and Respiratory Syndrome Vaccine
Swine Fever Vaccine
Pseudorabies Vaccine
Others
Market Segmentation (by Application)
Breeding Farm
Veterinary Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Swine Live Vaccine Market
Overview of the regional outlook of the Swine Live Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Swine Live Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Swine Live Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The swine live vaccine market encompasses biological preparations designed to stimulate immunity in pigs against specific diseases, utilizing attenuated or modified live pathogens that replicate within the host to induce a robust immune response. These vaccines are critical in preventing outbreaks of diseases such as porcine reproductive and respiratory syndrome (PRRS), classical swine fever (CSF), and porcine circovirus-associated diseases (PCVAD), which can cause significant economic losses in the swine industry. The market is driven by increasing pork consumption, rising awareness of animal health, and stringent biosecurity regulations in livestock farming. Technological advancements in vaccine development, such as vector-based and recombinant DNA vaccines, are enhancing efficacy and safety. However, challenges include high R&D costs, regulatory hurdles, and the need for cold chain logistics to maintain vaccine viability. Geographically, Asia-Pacific dominates due to large-scale pig farming in China and Vietnam, while North America and Europe focus on advanced vaccine solutions to meet stringent food safety standards. The growing trend toward antibiotic-free farming further boosts demand for effective live vaccines as alternatives to antimicrobials. Key players in the market include Zoetis, Merck Animal Health, Boehringer Ingelheim, and Ceva Santé Animale, who invest heavily in innovation and strategic partnerships to expand their product portfolios and global reach.
The global Swine Live Vaccine market size was estimated at USD 1952.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.12% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Swine Live Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Swine Live Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Swine Live Vaccine market.
Global Swine Live Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boehringer Ingelheim
Harbin Pharmaceutical Group Bio-vaccine
DHN
Shenzhen BIOCBD Biotechnology
Jinyu Biotechnology
Zhongmu Industry
Qindao Lijian Bio-Tech
Wuhan Keqian Biology
Ceva Corporate
KM Biologics
Nisseiken
Market Segmentation (by Type)
Porcine Reproductive and Respiratory Syndrome Vaccine
Swine Fever Vaccine
Pseudorabies Vaccine
Others
Market Segmentation (by Application)
Breeding Farm
Veterinary Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Swine Live Vaccine Market
Overview of the regional outlook of the Swine Live Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Swine Live Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Swine Live Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
142 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Swine Live Vaccine
- 1.2 Key Market Segments
- 1.2.1 Swine Live Vaccine Segment by Type
- 1.2.2 Swine Live Vaccine Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Swine Live Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Swine Live Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Swine Live Vaccine Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Swine Live Vaccine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Swine Live Vaccine Product Life Cycle
- 3.3 Global Swine Live Vaccine Sales by Manufacturers (2020-2025)
- 3.4 Global Swine Live Vaccine Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Swine Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Swine Live Vaccine Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Swine Live Vaccine Market Competitive Situation and Trends
- 3.8.1 Swine Live Vaccine Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Swine Live Vaccine Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Swine Live Vaccine Industry Chain Analysis
- 4.1 Swine Live Vaccine Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Swine Live Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Swine Live Vaccine Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Swine Live Vaccine Market
- 5.7 ESG Ratings of Leading Companies
- 6 Swine Live Vaccine Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Swine Live Vaccine Sales Market Share by Type (2020-2025)
- 6.3 Global Swine Live Vaccine Market Size Market Share by Type (2020-2025)
- 6.4 Global Swine Live Vaccine Price by Type (2020-2025)
- 7 Swine Live Vaccine Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Swine Live Vaccine Market Sales by Application (2020-2025)
- 7.3 Global Swine Live Vaccine Market Size (M USD) by Application (2020-2025)
- 7.4 Global Swine Live Vaccine Sales Growth Rate by Application (2020-2025)
- 8 Swine Live Vaccine Market Sales by Region
- 8.1 Global Swine Live Vaccine Sales by Region
- 8.1.1 Global Swine Live Vaccine Sales by Region
- 8.1.2 Global Swine Live Vaccine Sales Market Share by Region
- 8.2 Global Swine Live Vaccine Market Size by Region
- 8.2.1 Global Swine Live Vaccine Market Size by Region
- 8.2.2 Global Swine Live Vaccine Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Swine Live Vaccine Sales by Country
- 8.3.2 North America Swine Live Vaccine Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Swine Live Vaccine Sales by Country
- 8.4.2 Europe Swine Live Vaccine Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Swine Live Vaccine Sales by Region
- 8.5.2 Asia Pacific Swine Live Vaccine Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Swine Live Vaccine Sales by Country
- 8.6.2 South America Swine Live Vaccine Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Swine Live Vaccine Sales by Region
- 8.7.2 Middle East and Africa Swine Live Vaccine Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Swine Live Vaccine Market Production by Region
- 9.1 Global Production of Swine Live Vaccine by Region(2020-2025)
- 9.2 Global Swine Live Vaccine Revenue Market Share by Region (2020-2025)
- 9.3 Global Swine Live Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Swine Live Vaccine Production
- 9.4.1 North America Swine Live Vaccine Production Growth Rate (2020-2025)
- 9.4.2 North America Swine Live Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Swine Live Vaccine Production
- 9.5.1 Europe Swine Live Vaccine Production Growth Rate (2020-2025)
- 9.5.2 Europe Swine Live Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Swine Live Vaccine Production (2020-2025)
- 9.6.1 Japan Swine Live Vaccine Production Growth Rate (2020-2025)
- 9.6.2 Japan Swine Live Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Swine Live Vaccine Production (2020-2025)
- 9.7.1 China Swine Live Vaccine Production Growth Rate (2020-2025)
- 9.7.2 China Swine Live Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Boehringer Ingelheim
- 10.1.1 Boehringer Ingelheim Basic Information
- 10.1.2 Boehringer Ingelheim Swine Live Vaccine Product Overview
- 10.1.3 Boehringer Ingelheim Swine Live Vaccine Product Market Performance
- 10.1.4 Boehringer Ingelheim Business Overview
- 10.1.5 Boehringer Ingelheim SWOT Analysis
- 10.1.6 Boehringer Ingelheim Recent Developments
- 10.2 Harbin Pharmaceutical Group Bio-vaccine
- 10.2.1 Harbin Pharmaceutical Group Bio-vaccine Basic Information
- 10.2.2 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Overview
- 10.2.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Market Performance
- 10.2.4 Harbin Pharmaceutical Group Bio-vaccine Business Overview
- 10.2.5 Harbin Pharmaceutical Group Bio-vaccine SWOT Analysis
- 10.2.6 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
- 10.3 DHN
- 10.3.1 DHN Basic Information
- 10.3.2 DHN Swine Live Vaccine Product Overview
- 10.3.3 DHN Swine Live Vaccine Product Market Performance
- 10.3.4 DHN Business Overview
- 10.3.5 DHN SWOT Analysis
- 10.3.6 DHN Recent Developments
- 10.4 Shenzhen BIOCBD Biotechnology
- 10.4.1 Shenzhen BIOCBD Biotechnology Basic Information
- 10.4.2 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Overview
- 10.4.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Market Performance
- 10.4.4 Shenzhen BIOCBD Biotechnology Business Overview
- 10.4.5 Shenzhen BIOCBD Biotechnology Recent Developments
- 10.5 Jinyu Biotechnology
- 10.5.1 Jinyu Biotechnology Basic Information
- 10.5.2 Jinyu Biotechnology Swine Live Vaccine Product Overview
- 10.5.3 Jinyu Biotechnology Swine Live Vaccine Product Market Performance
- 10.5.4 Jinyu Biotechnology Business Overview
- 10.5.5 Jinyu Biotechnology Recent Developments
- 10.6 Zhongmu Industry
- 10.6.1 Zhongmu Industry Basic Information
- 10.6.2 Zhongmu Industry Swine Live Vaccine Product Overview
- 10.6.3 Zhongmu Industry Swine Live Vaccine Product Market Performance
- 10.6.4 Zhongmu Industry Business Overview
- 10.6.5 Zhongmu Industry Recent Developments
- 10.7 Qindao Lijian Bio-Tech
- 10.7.1 Qindao Lijian Bio-Tech Basic Information
- 10.7.2 Qindao Lijian Bio-Tech Swine Live Vaccine Product Overview
- 10.7.3 Qindao Lijian Bio-Tech Swine Live Vaccine Product Market Performance
- 10.7.4 Qindao Lijian Bio-Tech Business Overview
- 10.7.5 Qindao Lijian Bio-Tech Recent Developments
- 10.8 Wuhan Keqian Biology
- 10.8.1 Wuhan Keqian Biology Basic Information
- 10.8.2 Wuhan Keqian Biology Swine Live Vaccine Product Overview
- 10.8.3 Wuhan Keqian Biology Swine Live Vaccine Product Market Performance
- 10.8.4 Wuhan Keqian Biology Business Overview
- 10.8.5 Wuhan Keqian Biology Recent Developments
- 10.9 Ceva Corporate
- 10.9.1 Ceva Corporate Basic Information
- 10.9.2 Ceva Corporate Swine Live Vaccine Product Overview
- 10.9.3 Ceva Corporate Swine Live Vaccine Product Market Performance
- 10.9.4 Ceva Corporate Business Overview
- 10.9.5 Ceva Corporate Recent Developments
- 10.10 KM Biologics
- 10.10.1 KM Biologics Basic Information
- 10.10.2 KM Biologics Swine Live Vaccine Product Overview
- 10.10.3 KM Biologics Swine Live Vaccine Product Market Performance
- 10.10.4 KM Biologics Business Overview
- 10.10.5 KM Biologics Recent Developments
- 10.11 Nisseiken
- 10.11.1 Nisseiken Basic Information
- 10.11.2 Nisseiken Swine Live Vaccine Product Overview
- 10.11.3 Nisseiken Swine Live Vaccine Product Market Performance
- 10.11.4 Nisseiken Business Overview
- 10.11.5 Nisseiken Recent Developments
- 11 Swine Live Vaccine Market Forecast by Region
- 11.1 Global Swine Live Vaccine Market Size Forecast
- 11.2 Global Swine Live Vaccine Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Swine Live Vaccine Market Size Forecast by Country
- 11.2.3 Asia Pacific Swine Live Vaccine Market Size Forecast by Region
- 11.2.4 South America Swine Live Vaccine Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Swine Live Vaccine by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Swine Live Vaccine Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Swine Live Vaccine by Type (2026-2033)
- 12.1.2 Global Swine Live Vaccine Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Swine Live Vaccine by Type (2026-2033)
- 12.2 Global Swine Live Vaccine Market Forecast by Application (2026-2033)
- 12.2.1 Global Swine Live Vaccine Sales (K MT) Forecast by Application
- 12.2.2 Global Swine Live Vaccine Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
